Pancreatic solid incidentalomas
Open accessAbstract
INTRODUCTION In the changing landscape of modern medicine, the use of advanced imaging studies is constantly increasing. This trend has led to an increase in incidental findings on imaging examinations performed for unrelated causes, colloquially termed “incidentalomas.” The reported prevalence of pancreatic incidentalomas (PIs) varies greatly in different series and differs between cystic and solid lesions. In two large series, Laffan et al.[1] and de Jong et al.[2] reported that the prevalence of unsuspected pancreatic cysts discovered by multidetector computerized tomography or magnetic resonance imaging (MRI) is 2.4%–2.6%, and the prevalence increased with age. This figure is even higher (9.3%) when using high-resolution MRI.[3] As cystic lesions are common, a number of guidelines addressing their management have been issued.[45] The prevalence of solid PIs is less clear. Strang et al. reported a 0.6% prevalence of pancreatic masses in healthy potential kidney donors;[6] a similar prevalence of 0.49% was reported among 2941 patients undergoing 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) for unrelated causes.[7] Of 39,785 FDG-PET scans performed for cancer screening in Japan, the prevalence of pancreatic malignancy was lower than 0.001%;[8] a figure more closely related to SEER (The Surveillance, Epidemiology, and End Results Program) reported a new pancreatic cancer incidence of 12.5/100,000.[9] The differential diagnosis of pancreatic solid lesions is broad and includes malignancy (exocrine, endocrine, lymphoproliferative, or metastatic tumors), premalignant lesions (solid pseudopapillary tumors and low-grade neuroendocrine tumor [NET]), and focal inflammatory or infectious causes. Rarer diagnoses have also been described.[10] SOLID PANCREATIC INCIDENTALOMA The characteristics of these incidentalomas are derived mostly from data provided from retrospective pancreatic resection series published in recent years [Table 1]. In these series, the proportion of incidental findings varied from 6% to 61%.Table 1: Characteristics of pancreatic incidentalomasThe percentage of solid lesions was 31%–65% of all lesions incidentally identified. The four most common diagnoses of these solid lesions were pancreatic carcinoma (34%–31%), pancreatic NET (pNET, 23%–42%), solid pseudopapillary tumor (3%–15%), and focal chronic pancreatitis (0%–11%). The low prevalence of focal chronic pancreatitis is similar to that of 4.8%–6.3% in large pancreatoduodenectomy cohorts described in two historical series from the United States[20] and from Holland.[21] In a recent multicenter Italian trial[22] on endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB), pancreatic inflammation was diagnosed in 13% of 333 biopsies taken. Pancreatic carcinoma (70%) and pNET (11%) were the other common diagnoses in that trial. PANCREATIC CARCINOMA The most common cause of an incidentally identified solid lesion is pancreatic ductal adenocarcinoma (PDAC). In a review of 475 pancreatic resections, Lahat et al.[14] showed that the tumor was smaller in incidental compared to symptomatic lesions (2.5 cm vs. 3.5 cm) and was more likely to be well differentiated (37.5% vs. 14.8%). Interestingly, the rate of lymph node (LN) involvement was similar between the two groups, and median survival was not significantly different (22 months vs. 19 months). Takeda et al.[16] reviewed 569 PDAC patients; 250 were resectable. Overall tumor resectability (64% vs. 36%) and median survival (16 months vs. 10 months) were higher in patients with incidental compared with symptomatic lesions. In patients who underwent surgery, LN involvement was similar between the groups (68% vs. 77%) and a trend of increased median survival was observed (31 months vs. 20 months). In a review of 1826 pancreatoduodenectomies, Winter et al.[11] found that the likelihood of diagnosis in Stage I was higher (34% vs. 10%) in incidentally identified PDAC, and 5-year survival rates were 50% vs. 14%. Agarwal et al.[23] showed that patients with a smaller tumor size had a higher proportion of resectable tumors and a better median survival. Tumors smaller than 2 cm had a median survival time of 17.2 months compared to 7.6 months in tumors over 3 cm. Takeda et al.[16] showed that in the rare cases of tumors smaller than 1.5 cm, LN involvement was only 14%, compared to 76% when the tumor was over 2 cm. R0 resection was achieved in all cases when the tumor was smaller than 2 cm, compared to 80% for larger tumors. PANCREATIC NEUROENDOCRINE TUMORS The second most common cause of a solid PI is a pNET. Birnbaum et al.[17] presented the prognostic significance of incidental discovery of pNET in a series of 108 patients. Tumors discovered incidentally were more likely to be smaller than 2 cm (65% vs. 42%) and with G1 differentiation (66% vs. 33%). Patients undergoing surgery had a higher rate of pancreatic-sparing resections (62% vs. 30%), but there was no change in the rate of perioperati
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Among solid lesions found incidentally in the pancreas, pancreatic cancer is the most commonly found lesion, with a rate of approximately 31-34%.
“Among solid lesions found incidentally in the pancreas, pancreatic cancer is the most commonly found lesion, with a rate of approximately 31–34% (22).”
From Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer (2023) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354 · see citing works
Falconi, M., Eriksson, B. K., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M. E., Kos‐Kudła, B., Kwekkeboom, D. J., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,361 · see citing works
Vege, S. S., Ziring, B., Jain, R., Moayyedi, P., Adams, M. A., Dorn, S. D., Dudley-Brown, S. L., Flamm, S. L., Gellad, Z. F., Gruss, C. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.015 · Cited by 1,138 · see citing works
Prevalence of Unsuspected Pancreatic Cysts on MDCT
Laffan, T. A., Horton, K. M., Klein, A. P., Berlanstein, B. P., Siegelman, S. S., Kawamoto, S., Johnson, P. T., Fishman, E. K., & Hruban, R. H. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3340 · Cited by 882 · see citing works
High Prevalence of Pancreatic Cysts Detected by Screening Magnetic Resonance Imaging Examinations
de Jong, K., Nio, C. Y., Hermans, J. J., Dijkgraaf, M. G. W., Gouma, D. J., van Eijck, C. H. J., van Heel, E., Klaß, G., Fockens, P., & Bruno, M. J. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.05.017 · Cited by 533 · see citing works
Pai, M. (2015) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v7.i4.52 · Cited by 251 · see citing works
Changing Incidence of Pancreatic Neoplasms
Fitzgerald, T. L., Hickner, Z. J., Schmitz, M., & Kort, E. J. (2008) · Pancreas · doi:10.1097/mpa.0b013e318163a329 · Cited by 174 · see citing works
Lakhtakia, S., Ramchandani, M. J., Galasso, D., Gupta, R., Venugopal, S., Kalpala, R., & Reddy, D. N. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.08.085 · Cited by 168 · see citing works
Winter, J. M., Cameron, J. L., Lillemoe, K. D., Campbell, K. A., Chang, D., Riall, T. S., Coleman, J., Sauter, P. K., Canto, M., Hruban, R. H., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000216763.27673.97 · Cited by 156 · see citing works
van Gulik, T. M., Reeders, J. W. A. J., Bosma, A., Moojen, T. M., Smits, N. J., Allema, J. H., RAUWS, E., Offerhaus, G. J. A., Obertop, H., & Gouma, D. J. (1997) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(97)70034-8 · Cited by 150 · see citing works
Radical pancreatoduodenectomy for misdiagnosed pancreatic mass
Smith, C. D., Behrns, K. E., van Heerden, J. A., & Sarr, M. G. (1994) · British journal of surgery · doi:10.1002/bjs.1800810435 · Cited by 135 · see citing works
Radiofrequency Ablation of Pancreatic Neuroendocrine Tumors
Rossi, S. M., Viera, F. T., Ghittoni, G., Cobianchi, L., Rosa, L. L., Siciliani, L., Bortolotto, C., Veronese, L., Vercelli, A., Gallotti, A., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000133 · Cited by 111 · see citing works
Survival in Pancreatic Carcinoma Based on Tumor Size
Agarwal, B., Correa, A. M., & Ho, L. (2008) · Pancreas · doi:10.1097/mpa.0b013e31814de421 · Cited by 102 · see citing works
Crippa, S., Partelli, S., Zamboni, G., Scarpa, A., Tamburrino, D., Bassi, C., Pederzoli, P., & Falconi, M. (2014) · Surgery · doi:10.1016/j.surg.2013.08.002 · Cited by 97 · see citing works
The Incidental Asymptomatic Pancreatic Lesion: Nuisance or Threat?
Sachs, T. E., Pratt, W. B., Callery, M. P., & Vollmer, C. M. (2009) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0788-0 · Cited by 81 · see citing works
Prevalence of Incidental Pancreatic Cysts on 3 Tesla Magnetic Resonance
de Oliveira, P. B., Puchnick, A., Szejnfeld, J., & Goldman, S. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121317 · Cited by 76 · see citing works
Pancreatic Incidentalomas: High Rate of Potentially Malignant Tumors
Lahat, G., Haim, M. B., Nachmany, I., Sever, R., Blachar, A., Nakache, R., & Klausner, J. M. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.05.009 · Cited by 71 · see citing works
Birnbaum, D. J., Gaujoux, S., Cherif, R., Dokmak, S., Fuks, D., Couvelard, A., Vullierme, M., Ronot, M., Ruszniewski, P. B., Belghiti, J., et al. (2013) · Surgery · doi:10.1016/j.surg.2013.08.007 · Cited by 66 · see citing works
Pancreatic incidentalomas: clinical and pathologic spectrum
Bruzoni, M., Johnston, E., & Sasson, A. R. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.12.027 · Cited by 50 · see citing works
Fabbri, C., Fuccio, L., Fornelli, A., Antonini, F., Liotta, R., Frazzoni, L., Larghi, A., Maimone, A., Paggi, S., Gusella, P., et al. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-4960-4 · Cited by 41 · see citing works
Computerized Tomographic Angiography for Renal Donor Evaluation Leads to a Higher Exclusion Rate
Strang, A. M., Lockhart, M. E., Kenney, P. J., Amling, C. L., Urban, D. A., El-Galley, R., Burns, J. R., Colli, J. L., Hammontree, L. N., & Kolettis, P. N. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.007 · Cited by 31 · see citing works
Asymptomatic pancreatic cancer: does incidental detection impact long-term outcomes?
Takeda, Y., Saiura, A., Takahashi, Y., Inoue, Y., Ishizawa, T., Mise, Y., Matsumura, M., Ichida, H., Matsuki, R., Tanaka, M., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3421-2 · Cited by 27 · see citing works
Prevalence of Unsuspected Pancreatic Cysts on MDCT
Levy, A. D. (2009) · Yearbook of Diagnostic Radiology · doi:10.1016/s0098-1672(09)79302-6 · Cited by 25 · see citing works
Incidentally discovered solid pancreatic masses: imaging and clinical observations
Goodman, M., Willmann, J. K., & Jeffrey, R. B. (2011) · Abdominal Imaging · doi:10.1007/s00261-011-9720-2 · Cited by 23 · see citing works
Is whole-body FDG-PET valuable for health screening?
Weckesser, M., & Schober, O. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1775-2 · Cited by 22 · see citing works
Hocke, M., & Dietrich, C. F. (2012) · International Journal of Inflammation · doi:10.1155/2012/420787 · Cited by 19 · see citing works
Aace/Ace Disease State Clinical Review: Pancreatic Neuroendocrine Incidentalomas
Herrera, M. F., Åkerström, G., Angelos, P., Grant, C. S., Hoff, A. O., Pantoja, J. P., Pérez-Johnston, R., Sahani, D. V., Wong, R. J., & Randolph, G. W. (2015) · Endocrine Practice · doi:10.4158/ep14465.dsc · Cited by 18 · see citing works
Levy, A. D. (2007) · Yearbook of Diagnostic Radiology · doi:10.1016/s0098-1672(08)70198-x · Cited by 15 · see citing works
Unsuspected Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)–Positive Pancreatic Lesions
Pitts, A., Nissen, N. N., Waxman, A., & Yu, R. (2013) · Pancreas · doi:10.1097/mpa.0b013e318287d06e · Cited by 8 · see citing works
Left-sided pancreatic incidentalomas treated with laparoscopic approach: a report of 20 cases
Chiarelli, M. E., Gerosa, M., Tagliabue, F., Fumagalli, L. A. M., Guttadauro, A., Gabrielli, F., Marando, A., Simone, M. D., & Cioffi, U. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0949-7 · Cited by 8 · see citing works
Herrera, M. F., Pantoja, J. P., Salazar, M. S., & Velázquez‐Fernández, D. (2009) · Springer eBooks · doi:10.1007/978-1-84628-881-4_41 · Cited by 5 · see citing works
251 The Incidental Asymptomatic Pancreatic Lesion: Nuisance or Threat?
Sachs, T. E., Pratt, W. B., Callery, M. P., & Vollmer, C. M. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)63949-9 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Clinical features and prognostic impact of asymptomatic pancreatic cancer
Takikawa, T., Kikuta, K., Hamada, S., Kume, K., Miura, S., Yoshida, N., Tanaka, Y., Matsumoto, R., Ikeda, M., Kataoka, F., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08083-6 · Cited by 47 · see citing works
Diagnostic strategy with a solid pancreatic mass
Guarneri, G., Gasparini, G., Crippa, S., Andreasi, V., & Falconi, M. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.02.026 · Cited by 31 · see citing works
Sundaram, S. (2023) · Annals of Gastroenterology · doi:10.20524/aog.2023.0790 · Cited by 25 · see citing works
Cohen, A. S., Li, J., Hight, M. R., McKinley, E. T., Fu, A., Payne, A. C., Liu, Y., Zhang, D., Xie, Q., Bai, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1214 · Cited by 16 · see citing works
Chandan, S., Mohan, B. P., Khan, S. R., Ofosu, A., Dhaliwal, A., Shah, A. R., Bhogal, N., Mashiana, H. S., Mashiana, S. S., Kassab, L. L., et al. (2020) · Endoscopy International Open · doi:10.1055/a-1240-0027 · Cited by 21 · see citing works
Caban, M., & Małecka-Wojciesko, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164648 · Cited by 19 · see citing works
Mascarenhas, M., González-Haba, M., Widmer, J. L., Mendes, F., Gonda, T. A., Agudo, B., Ribeiro, T., da Costa, A. M. P., Fazel, Y., Lera, M. E., et al. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000771 · Cited by 16 · see citing works
Potential Role for Observation in Small Solid Pseudopapillary Neoplasm (SPN)
Standring, O. J., Sanchez, S. B., Pasha, S., Demyan, L., Lad, N. L., Ruff, S. M., Anantha, S., Karpeh, M. S., Newman, E., Nealon, W. H., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13496-2 · Cited by 14 · see citing works
Saghir, S. M., Dhindsa, B. S., Daid, S. G. S., Mashiana, H. S., Dhaliwal, A., Cross, C. L., Singh, S., Bhat, I., Ohning, G., & Adler, D. G. (2021) · Endoscopic Ultrasound · doi:10.4103/eus-d-20-00122 · Cited by 11 · see citing works
Standard reporting elements for the performance of EUS: Recommendations from the FOCUS working group
James, P. D., Li, S., Monachese, M., Salim, M., Arya, N., Sahai, A. V., Forbes, N., Teshima, C., Yaghoobi, M., Chen, Y., et al. (2021) · Endoscopic Ultrasound · doi:10.4103/eus-d-20-00234 · Cited by 11 · see citing works
Park, B. K., Koh, H. D., Won, S. Y., Cho, Y. S., Seo, J. H., An, C., & Park, S. (2023) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-863 · Cited by 10 · see citing works
“Among solid lesions found incidentally in the pancreas, pancreatic cancer is the most commonly found lesion, with a rate of approximately 31–34% (22).”
Higashi, M., Tanabe, M., Onoda, H., Nakao, S., Miyoshi, K., Iida, E., Okada, M., Furukawa, M., & Ito, K. (2020) · Abdominal Radiology · doi:10.1007/s00261-019-02365-w · Cited by 10 · see citing works
Cao, C., Sharib, J. M., Blanco, A. M., Goldberg, D., Bracci, P. M., Mukhtar, R. A., Esserman, L. J., & Kirkwood, K. S. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.09.019 · Cited by 8 · see citing works
Vining, C. C., Hsu, P. J., Schuitevoerder, D., Joseph, N. E., & Hogg, M. E. (2020) · Journal of Pancreatic Cancer · doi:10.1089/pancan.2020.0009 · Cited by 6 · see citing works
Resectable pancreatic solid lesions: Time to move from surgical diagnosis?
Larghi, A., Rimbaș, M., Rizzatti, G., Quero, G., Gasbarrini, A., Costamagna, G., & Alfieri, S. (2020) · Endoscopic Ultrasound · doi:10.4103/eus.eus_67_19 · Cited by 6 · see citing works
Imaging‑based diagnosis of intrapancreatic accessory spleen: A case report
Kovačević, K., Puškarić, B. J., & Kovačević, D. O. (2024) · Biomedical Reports · doi:10.3892/br.2024.1801 · Cited by 2 · see citing works
Solitary Fibrous Tumor of the Pancreas
McKenzie, J., Bates, W., & Kruse, E. (2019) · The American Surgeon · doi:10.1177/000313481908500914 · Cited by 2 · see citing works
Halim, N. A., Sadot, E., & Negoi, I. (2025) · Cancers · doi:10.3390/cancers17193243 · Cited by 1 · see citing works
Abdellatif, T. E., Safwat, K., El-Menshawy, H. H. E.-B., Abdalla, W. M., & Naguib, S. M. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00567-w
EUS‐Guided FNA/FNB for Pancreatic Solid Lesions
Rimbaș, M., Rizzatti, G., & Larghi, A. (2021) · doi:10.1002/9781119570097.ch57
Overview of Pancreatic Masses and Cystic Lesions
Pezzilli, R. (2021) · Springer eBooks · doi:10.1007/978-3-030-71937-1_1
Martinez-Esteban, A., Fuentes-Calvo, K. J., Barron-Cervantes, N. M., Flores, A., Ramos-Aranda, J., Arias-Ruiz, L. F., & Chan, C. H. F. (2024) · Cureus · doi:10.7759/cureus.60116
Essoun, S. A., Adu-Aryee, N. A., Obaka, H. E., Seshie, B. K., Dey, D. I., & Naporo, S. (2024) · Oxford Medical Case Reports · doi:10.1093/omcr/omae104
Chen, Z.-Y., Wang, Y.-Q., Tan, X.-Z., Liu, P., & Peng, Y. (2026) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v18.i4.117976
Acharya, S., Meredith, L. T., Kaplan, Z., Persaud, R., Moskal, D., Wummer, B. M., Jiang, W., Zheng, R., Naringrekar, H., Lavu, H., et al. (2026) · Journal of Surgical Oncology · doi:10.1002/jso.70248
Wołyniak, M., Zheng, E., Polak, M., Trojanowski, S., & Malecka-Panas, E. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125468
- Authors
- Santo, E., & Bar-Yishay, I.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Santo, Erwin
- ORCID
- Bar-Yishay, Iddo
- Venue
- Endoscopic Ultrasound
- Published
- 2017
- Volume
- 6
- Issue
- 9
- Pages
- 99
- ISSN
- 2226-7190 (ISSN-L)
- 2303-9027
- PMC
- PMC5774085
- OpenAlex
- W2794414148
- Cited by
- 26
- References
- 32
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 4
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- Endoscopic Ultrasound (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Oncology › Peptidase Inhibition and Analysis
- Keywords
- solid pancreatic lesions, prevalence, pancreatic cancer, pancreatic neuroendocrine tumors, solid pseudopapillary neoplasm, differential diagnosis, pancreatic resection, pancreatic cysts, pancreatic cancer screening, pancreatic metastasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
